Contrary to its stated goal of reducing prescription-drug prices, the Inflation Reduction Act (IRA) is likely to drive drug prices higher and delay or prevent the release of new drugs, especially those for rare conditions. “IRA has made perverse incentives, so certain things don’t work anymore from a financial perspective,” David Epstein, the former CEO ...
The post Biden’s Inflation Reduction Act Will Hike Prescription-drug Prices, Delay New Drugs appeared first on The New American.
